Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot-Assisted colon surgery: a new tool under the microscope

NCT ID NCT07123051

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing a new robotic system called DEXTER to help surgeons perform a right colectomy, which is the removal of the right part of the colon. The goal is to see if the robot is safe and works well during and right after surgery. About 33 adults who need this surgery will take part, and they will be followed for 30 days after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DEXTER robotic surgery system
What this could lead to
If successful, this could show that the DEXTER robot is a safe and effective tool for performing right colectomy, potentially offering a new surgical option.
What could go wrong
This is a small, early-stage study with only 33 participants, so results may not apply to everyone. There are standard surgical risks like infection or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 33 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients undergoing a right colectomy for malignant or benign indication

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged \> 18 years * Patient agrees to perform the 30-day follow-up assessment as per standard of care Exclusion Criteria: * History of radiotherapy on the target surgical area * Patients with distant metastasis * Any planned concomitant procedures * History of major abdominal surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Right colectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Artemed Klinikum München Süd

    NOT_YET_RECRUITING

    Munich, 81379, Germany

  • CH Châteauroux - Le Blanc

    RECRUITING

    Châteauroux, 36000, France

  • SRO AG Spital Langenthal

    RECRUITING

    Langenthal, 4900, Switzerland

  • Spitäler FMI AG

    RECRUITING

    Interlaken, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.